396 related articles for article (PubMed ID: 23896411)
1. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells.
Chu LY; Ramakrishnan DP; Silverstein RL
Blood; 2013 Sep; 122(10):1822-32. PubMed ID: 23896411
[TBL] [Abstract][Full Text] [Related]
2. Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.
Kazerounian S; Duquette M; Reyes MA; Lawler JT; Song K; Perruzzi C; Primo L; Khosravi-Far R; Bussolino F; Rabinovitz I; Lawler J
Blood; 2011 Apr; 117(17):4658-66. PubMed ID: 21378271
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of antiangiogenic thrombospondin-1 type 1 repeat domain interactions with CD36.
Klenotic PA; Page RC; Li W; Amick J; Misra S; Silverstein RL
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1655-62. PubMed ID: 23640500
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level.
Zhang X; Kazerounian S; Duquette M; Perruzzi C; Nagy JA; Dvorak HF; Parangi S; Lawler J
FASEB J; 2009 Oct; 23(10):3368-76. PubMed ID: 19528255
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.
Ren B; Hale J; Srikanthan S; Silverstein RL
Blood; 2011 Jun; 117(22):6036-45. PubMed ID: 21441463
[TBL] [Abstract][Full Text] [Related]
6. Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth.
Hale JS; Li M; Sinyuk M; Jahnen-Dechent W; Lathia JD; Silverstein RL
PLoS One; 2012; 7(7):e40033. PubMed ID: 22808089
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles Activate a CD36-Dependent Signaling Pathway to Inhibit Microvascular Endothelial Cell Migration and Tube Formation.
Ramakrishnan DP; Hajj-Ali RA; Chen Y; Silverstein RL
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):534-44. PubMed ID: 26821945
[TBL] [Abstract][Full Text] [Related]
8. CD36: a critical anti-angiogenic receptor.
Simantov R; Silverstein RL
Front Biosci; 2003 Sep; 8():s874-82. PubMed ID: 12957861
[TBL] [Abstract][Full Text] [Related]
9. Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
Paquin-Veillette J; Lizotte F; Robillard S; Béland R; Breton MA; Guay A; Despatis MA; Geraldes P
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2291-2300. PubMed ID: 29074590
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.
Kaur S; Martin-Manso G; Pendrak ML; Garfield SH; Isenberg JS; Roberts DD
J Biol Chem; 2010 Dec; 285(50):38923-32. PubMed ID: 20923780
[TBL] [Abstract][Full Text] [Related]
11. Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling.
Anderson CR; Hastings NE; Blackman BR; Price RJ
Am J Pathol; 2008 Oct; 173(4):1220-8. PubMed ID: 18772338
[TBL] [Abstract][Full Text] [Related]
12. The matricellular protein CCN1 controls retinal angiogenesis by targeting VEGF, Src homology 2 domain phosphatase-1 and Notch signaling.
Chintala H; Krupska I; Yan L; Lau L; Grant M; Chaqour B
Development; 2015 Jul; 142(13):2364-74. PubMed ID: 26002917
[TBL] [Abstract][Full Text] [Related]
13. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells.
Nakamura Y; Patrushev N; Inomata H; Mehta D; Urao N; Kim HW; Razvi M; Kini V; Mahadev K; Goldstein BJ; McKinney R; Fukai T; Ushio-Fukai M
Circ Res; 2008 May; 102(10):1182-91. PubMed ID: 18451337
[TBL] [Abstract][Full Text] [Related]
14. CD36-TSP-HRGP interactions in the regulation of angiogenesis.
Silverstein RL; Febbraio M
Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina.
Sun J; Hopkins BD; Tsujikawa K; Perruzzi C; Adini I; Swerlick R; Bornstein P; Lawler J; Benjamin LE
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1344-51. PubMed ID: 19304944
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD36 molecular features required for its in vitro angiostatic activity.
Primo L; Ferrandi C; Roca C; Marchiò S; di Blasio L; Alessio M; Bussolino F
FASEB J; 2005 Oct; 19(12):1713-5. PubMed ID: 16037098
[TBL] [Abstract][Full Text] [Related]
17. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins.
Short SM; Derrien A; Narsimhan RP; Lawler J; Ingber DE; Zetter BR
J Cell Biol; 2005 Feb; 168(4):643-53. PubMed ID: 15716381
[TBL] [Abstract][Full Text] [Related]
19. Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.
Willis CD; Poluzzi C; Mongiat M; Iozzo RV
FEBS J; 2013 May; 280(10):2271-84. PubMed ID: 23374253
[TBL] [Abstract][Full Text] [Related]
20. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
